RECRUITINGINTERVENTIONAL

The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years

The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years of Age or More at Risk of Losing Their Independance.

About This Trial

There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity. Hippotherapy is a nonconventional method which uses the horse in addition to standard care. The goal being to improve or maintain the gains of the person through cognitive, sensorial and motor stimulation, with the aim of improving quality of life and maintaining independence. With this in mind, the researchers propose to evaluate quality of life as the main criterion, using the PDQ8 scale validated for this disease. The researchers hope results will lead to the coverage of the costs of non-conventional therapies such as hippotherapy by social security services.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 75 years with PD according to Movement Disorders Society criteria (2015). - Clinical diagnosis of Alzheimer's disease - Has been on stable antiparkinsonian treatment for less than 3 months. - Ability to understand the principle of the study as well as its risks. - Written consent to participate in the trial. - Have social insurance - Agree to comply with all safety procedures during the study and its duration. - Ability to understand and freely give consent - Patient affiliated to social security or entitled beneficiary - Autonomy preserved Exclusion criteria : - age \<75 years - refusal to sign consent - MOCA \<23 - Presence of major behavioural problems that do not allow MRI to be performed under optimal conditions - Subjects unable to receive informed information, unable to participate in the study as a whole - Subjects with a diagnosis of atypical parkinsonian syndrome (Lewy body disease, progressive supranuclear palsy, multisystem atrophy, cortico-basal degeneration, etc.). - A classic contraindication to an MRI examination: claustrophobia, presence of incompatible foreign material, - Subjects who have practised horse riding at a high level, animal phobias, wish to stop studying, etc. - No affiliation to a social security scheme - Antiparkinsonian treatment has not been stable for at least 3 months. - People under protective supervision (guardianship, curatorship) - People under family guardianship are also excluded, as are people for whom a mandate for future protection has been activated. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Age ≥ 75 years with PD according to Movement Disorders Society criteria (2015). * Clinical diagnosis of Alzheimer's disease * Has been on stable antiparkinsonian treatment for less than 3 months. * Ability to understand the principle of the study as well as its risks. * Written consent to participate in the trial. * Have social insurance * Agree to comply with all safety procedures during the study and its duration. * Ability to understand and freely give consent * Patient affiliated to social security or entitled beneficiary * Autonomy preserved Exclusion criteria : * age \<75 years * refusal to sign consent * MOCA \<23 * Presence of major behavioural problems that do not allow MRI to be performed under optimal conditions * Subjects unable to receive informed information, unable to participate in the study as a whole * Subjects with a diagnosis of atypical parkinsonian syndrome (Lewy body disease, progressive supranuclear palsy, multisystem atrophy, cortico-basal degeneration, etc.). * A classic contraindication to an MRI examination: claustrophobia, presence of incompatible foreign material, * Subjects who have practised horse riding at a high level, animal phobias, wish to stop studying, etc. * No affiliation to a social security scheme * Antiparkinsonian treatment has not been stable for at least 3 months. * People under protective supervision (guardianship, curatorship) * People under family guardianship are also excluded, as are people for whom a mandate for future protection has been activated.

Treatments Being Tested

OTHER

hippotherapy sessions

Patients benefit from the hippotherapy sessions in additional to continuing to receive traditional care.

Locations (1)

Centre Hospitalier de Saint-Quentin;

Saint-Quentin, Aisne, France